The approval of immune checkpoint inhibitors (ICIs) was associated with a significant improvement in 2-year overall survival among patients with advanced-stage melanoma, non-small cell lung cancer ...

Split-Dose Cisplatin Plus Atezolizumab for Patients With Urothelial Carcinoma Who Are Considered Ineligible for Full Doses of Cisplatin (SOGUG-AUREA) In patients with mRCC, Medicare was associated ...

NEW YORK (Reuters Health) - People with cancers of the head or neck seem to have better survival odds if they have private health insurance, research hints. Head and neck cancers include cancers of ...

Marissa Russo is a former STAT intern supported by the AAAS Mass Media Science & Engineering Fellowship. As a cancer patient, access to innovative drugs can help extend your life — that is if you have ...